These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 6137963

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cyproheptadine in levodopa-induced dyskinesia in parkinsonism.
    Papavasilliou PS, Cotzias GC, McDowell FH, Rosal VL, Sheehan PJ.
    Clin Pharmacol Ther; 1978 Feb; 23(2):195-8. PubMed ID: 620480
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
    Bathien N, Rondot P, Koutlidis RM.
    J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Levodopa-induced dyskinesia: clinical observations.
    Friedman A.
    J Neurol; 1985 Apr; 232(1):29-31. PubMed ID: 3998772
    [Abstract] [Full Text] [Related]

  • 12. [Physiopathology of the dyskinesias induced by L-dopa].
    Grandas F, López-Ariztegui N.
    Rev Neurol; 1997 Aug; 25 Suppl 2():S151-6. PubMed ID: 9280682
    [Abstract] [Full Text] [Related]

  • 13. [Levodopa-induced dyskinesia in 176 patients with Parkinson's disease].
    Rocha MS, Andrade LA, Ferraz HB, Borges V.
    Arq Neuropsiquiatr; 1995 Dec; 53(4):737-42. PubMed ID: 8729765
    [Abstract] [Full Text] [Related]

  • 14. Edentulousness and neuroleptic-induced neck and trunk dyskinesia.
    Sandyk R, Kay SR.
    Funct Neurol; 1990 Dec; 5(4):361-3. PubMed ID: 1982665
    [Abstract] [Full Text] [Related]

  • 15. Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology.
    Marconi R, Lefebvre-Caparros D, Bonnet AM, Vidailhet M, Dubois B, Agid Y.
    Mov Disord; 1994 Jan; 9(1):2-12. PubMed ID: 8139601
    [Abstract] [Full Text] [Related]

  • 16. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
    Guigoni C, Aubert I, Li Q, Gurevich VV, Benovic JL, Ferry S, Mach U, Stark H, Leriche L, Håkansson K, Bioulac BH, Gross CE, Sokoloff P, Fisone G, Gurevich EV, Bloch B, Bezard E.
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S25-9. PubMed ID: 15885624
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease.
    Zesiewicz TA, Sullivan KL, Maldonado JL, Tatum WO, Hauser RA.
    Mov Disord; 2005 Sep; 20(9):1205-9. PubMed ID: 15954135
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.